Analysis-Sanofi CEO under pressure to woo investors after spending shock
(Reuters) -Sanofi's CEO is under pressure to tell investors how much more he will spend on research and development (R&D) and what the likely pay-offs will be, as he seeks to boost a pipeline of future drugs and restore shareholder trust. Shares in the 108 billion euro ($117 billion) French pharmaceutical giant tumbled 15% on Oct. 27 when CEO Paul Hudson unexpectedly abandoned 2025 margin targets in order to boost the budget for testing new immunology and inflammation drugs. The market's shock reaction, compounded by a lack of details of the spending push, overshadowed Sanofi...
Source: yahoo.com